Conference Coverage

Intense statin therapy treats atheromas in diabetes


 

AT ACC 13

*Correction, 3/27/13: An earlier version of this story incorrectly reported decreased TAV numbers for diabetics and nondiabetics. This version has been updated to reflect the correct numbers.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Pages

Recommended Reading

Ramipril boosts walking times in PAD with claudication
MDedge Cardiology
CDC: Address high smoking rate among mentally ill
MDedge Cardiology
Heart teams inch into routine cardiac practice
MDedge Cardiology
Critics dub JNC-8 as 'JNC-Late'
MDedge Cardiology
Fractional flow reserve the best tool for assessing intermediate stenoses
MDedge Cardiology
Cardiac stress testing underutilized in stroke patients
MDedge Cardiology
Atrial fibrillation device among top trials at ACC 13
MDedge Cardiology
Mummies may hold clues to atherosclerosis predisposition
MDedge Cardiology
TERISA targets diabetes as potential new market for ranolazine
MDedge Cardiology
Dual therapy shows promise for secondary cardiovascular prevention
MDedge Cardiology

Related Articles